KOD Earnings & Financial Statements
Kodiak Sciences Inc.
$86.36
+$0.58(+0.68%)
47
Overall
40
Value
66
Tech
36
Quality
Market Cap
$5.39B
Volume
153.83K
52W Range
$15.83 - $104.00
Target Price
$118.00
KOD earnings and financial statements: Kodiak Sciences Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
KOD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$234.39M | -$186.85M | -$277.32M | -$341.38M | -$267.05M |
| EBITDA | -$203.68M | -$149.51M | -$234.53M | -$322.75M | -$258.23M |
| Net income | -$229.97M | -$176.21M | -$260.49M | -$333.82M | -$266.99M |
| EPS (diluted) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $351.53M | $335.58M | $479.37M | $666.63M | $904.22M |
| Total liabilities | $194.15M | $185.29M | $213.59M | $230.46M | $240.90M |
| Shareholders’ equity | $157.38M | $150.29M | $265.78M | $436.17M | $663.32M |
| Cash and equivalents | $209.86M | $168.07M | $285.51M | $190.43M | $731.51M |
| Long-term debt | $47.12M | $59.72M | $71.86M | $77.81M | $76.06M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$136.00M | -$117.30M | -$154.20M | -$206.46M | -$182.27M |
| Capital expenditure | -$506.0K | -$375.0K | -$41.43M | -$47.36M | -$63.30M |
| Free cash flow | -$136.51M | -$117.67M | -$195.55M | -$253.82M | -$245.57M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KOD | $86.36 | +0.7% | 153.83K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |